ArticleCardiovascular diabetology2018

Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.

Sheng-Hua Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.